CDH1 and neoplasm: CAF-CM has been shown to drive the expression of mesenchymal markers such as vimentin, twist, and snail1 (all of which are associated with the epithelial-to-mesenchymal transition or EMT) and downregulate epithelial markers like E-cadherin in tumor cells [47,48,49].